NKAIN4

gene
On this page

Also known as bA261N11.2FAM77A

Summary

NKAIN4 (sodium/potassium transporting ATPase interacting 4, HGNC:16191) is a protein-coding gene on chromosome 20q13.33, encoding Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 (Q8IVV8).

NKAIN4 is a member of a family of mammalian proteins (see NKAIN1; MIM 612871) with similarity to Drosophila Nkain and interacts with the beta subunit of Na,K-ATPase (ATP1B1; MIM 182330) (Gorokhova et al., 2007 [PubMed 17606467]).

Source: NCBI Gene 128414 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 47 total
  • MANE Select transcript: NM_152864

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16191
Approved symbolNKAIN4
Namesodium/potassium transporting ATPase interacting 4
Location20q13.33
Locus typegene with protein product
StatusApproved
AliasesbA261N11.2, FAM77A
Ensembl geneENSG00000101198
Ensembl biotypeprotein_coding
OMIM612873
Entrez128414

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000370307, ENST00000370313, ENST00000370316, ENST00000370317, ENST00000461738, ENST00000466885, ENST00000470246, ENST00000472670, ENST00000486495

RefSeq mRNA: 3 — MANE Select: NM_152864 NM_001363718, NM_001363747, NM_152864

CCDS: CCDS13514, CCDS86967, CCDS86968

Canonical transcript exons

ENST00000370316 — 7 exons

ExonStartEnd
ENSE000018373076325439763254463
ENSE000034664666324253963242623
ENSE000034694796324757863247775
ENSE000034933006324993563250072
ENSE000035692806324881563248895
ENSE000035971706324078463241506
ENSE000036126246324402463244084

Expression profiles

Bgee: expression breadth ubiquitous, 175 present calls, max score 95.02.

FANTOM5 (CAGE): breadth broad, TPM avg 1.9057 / max 57.9344, expressed in 298 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1883331.5141283
1883340.3698188
1883310.01374
1883320.00621
1883280.00201

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
nucleus accumbensUBERON:000188295.02gold quality
amygdalaUBERON:000187695.00gold quality
putamenUBERON:000187493.67gold quality
hypothalamusUBERON:000189893.31gold quality
caudate nucleusUBERON:000187393.13gold quality
anterior cingulate cortexUBERON:000983591.72gold quality
substantia nigraUBERON:000203891.62gold quality
adrenal tissueUBERON:001830391.33gold quality
midbrainUBERON:000189190.57gold quality
temporal lobeUBERON:000187189.42gold quality
Ammon’s hornUBERON:000195488.83gold quality
ganglionic eminenceUBERON:000402388.43gold quality
right frontal lobeUBERON:000281088.26gold quality
Brodmann (1909) area 9UBERON:001354087.57gold quality
ventricular zoneUBERON:000305387.17gold quality
kidney epitheliumUBERON:000481987.14silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.89gold quality
C1 segment of cervical spinal cordUBERON:000646986.57gold quality
spinal cordUBERON:000224086.49gold quality
ventral tegmental areaUBERON:000269186.34gold quality
sural nerveUBERON:001548886.04gold quality
forebrainUBERON:000189085.89gold quality
adult mammalian kidneyUBERON:000008285.47gold quality
brainUBERON:000095585.36gold quality
dorsolateral prefrontal cortexUBERON:000983485.10gold quality
cerebral cortexUBERON:000095685.06gold quality
neocortexUBERON:000195084.54gold quality
metanephros cortexUBERON:001053384.45gold quality
prefrontal cortexUBERON:000045184.29gold quality
dorsal root ganglionUBERON:000004484.17gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-93593yes306.05
E-GEOD-84465yes24.36
E-ANND-3yes4.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

24 targeting NKAIN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-627-3P99.9071.423316
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-444799.8567.812900
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-430799.8270.453374
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-319999.1765.19696
HSA-MIR-805299.1765.01719
HSA-MIR-4716-5P98.8268.571168
HSA-MIR-314998.7767.131639
HSA-MIR-7851-3P98.7264.88980
HSA-MIR-557298.5565.84970
HSA-MIR-7156-3P98.2567.66859
HSA-MIR-744-3P97.9967.76637
HSA-MIR-425397.4865.11692
HSA-MIR-6862-5P97.4864.84713
HSA-MIR-6859-3P97.2664.69428
HSA-MIR-4712-5P97.2467.79775
HSA-MIR-770-5P97.2468.10758
HSA-MIR-6742-5P96.3264.01869
HSA-MIR-541-3P96.0766.111271
HSA-MIR-654-5P96.0766.181280

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerionkain4ENSDARG00000062699
mus_musculusNkain4ENSMUSG00000027574
rattus_norvegicusNkain4ENSRNOG00000031834
drosophila_melanogasterNKAINFBGN0085442
caenorhabditis_elegansWBGENE00011760

Paralogs (3): NKAIN1 (ENSG00000084628), NKAIN3 (ENSG00000185942), NKAIN2 (ENSG00000188580)

Protein

Protein identifiers

Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4Q8IVV8 (reviewed: Q8IVV8)

Alternative names: Protein FAM77A

All UniProt accessions (4): Q8IVV8, A6NNM2, J3JS66, J9JIE8

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Interacts with ATP1B1.

Subcellular location. Cell membrane.

Similarity. Belongs to the NKAIN family.

RefSeq proteins (3): NP_001350647, NP_001350676, NP_690603* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008516Na/K-Atpase_InteractingFamily

Pfam: PF05640

UniProt features (8 total): sequence variant 4, transmembrane region 3, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IVV8-F171.390.31

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 67 (showing top): AREB6_03, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, MYOD_Q6, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, LEIN_CEREBELLUM_MARKERS, NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON, HATADA_METHYLATED_IN_LUNG_CANCER_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, CBX5_TARGET_GENES, CEBPZ_TARGET_GENES, GREB1_TARGET_GENES

GO Biological Process (1): regulation of sodium ion transport (GO:0002028)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
sodium ion transport1
regulation of metal ion transport1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

536 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NKAIN4ATP1B1P05026821
NKAIN4AMZ1Q400G9493
NKAIN4CMYA5Q8N3K9493
NKAIN4CCDC57Q2TAC2474
NKAIN4FASTKD3Q14CZ7466
NKAIN4DNAJC12Q9UKB3459
NKAIN4DMRT3Q9NQL9456
NKAIN4RDM1Q8NG50452
NKAIN4LRRN4Q8WUT4447
NKAIN4FAM111AQ96PZ2447
NKAIN4STK31Q9BXU1446
NKAIN4FREM2Q5SZK8425
NKAIN4OR6T1Q8NGN1418
NKAIN4MESP2Q0VG99418
NKAIN4RASAL1O95294418

IntAct

5 interactions, top by confidence:

ABTypeScore
MALNKAIN4psi-mi:“MI:0915”(physical association)0.560
NKAIN4ENDOD1psi-mi:“MI:0914”(association)0.350
MALNKAIN4psi-mi:“MI:0915”(physical association)0.000

BioGRID (4): MAL (Two-hybrid), NKAIN4 (Negative Genetic), CAV2 (Affinity Capture-MS), ENDOD1 (Affinity Capture-MS)

ESM2 similar proteins: A2VE61, A6QNL6, Q0IHU6, Q0VFK3, Q17QL9, Q17R16, Q2YDG0, Q32NX4, Q3KRC4, Q3URJ8, Q401C0, Q4KMZ8, Q4PNJ2, Q5BL21, Q5R7B1, Q5R9I4, Q5RET6, Q5U4E0, Q5VXU1, Q5ZMP3, Q61088, Q66IV3, Q66KY5, Q68EY2, Q6DD32, Q6DEX3, Q6DHB5, Q6NYY9, Q6P360, Q6PHL4, Q7TSY2, Q7Z7J7, Q810F1, Q86UP9, Q8BXA5, Q8IVV8, Q8IWA5, Q8K3J9, Q8N8D7, Q8WVP7

Diamond homologs: A6MHQ4, A6QNL6, Q0IHU6, Q0VFH9, Q32NX4, Q3URJ8, Q4KMZ8, Q4PNJ2, Q5VXU1, Q66KY5, Q66KZ9, Q6DEX3, Q6PHL4, Q8IVV8, Q8N8D7, Q9D035, Q9JMG4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

47 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance37
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1495 predictions. Top by Δscore:

VariantEffectΔscore
20:63247572:GCTCA:Gdonor_loss1.0000
20:63247573:CTCA:Cdonor_loss1.0000
20:63247574:TCA:Tdonor_loss1.0000
20:63247575:CA:Cdonor_loss1.0000
20:63247576:A:ACdonor_gain1.0000
20:63247577:C:CCdonor_gain1.0000
20:63247577:C:CTdonor_loss1.0000
20:63247577:CCG:Cdonor_gain1.0000
20:63247771:CTGTC:Cacceptor_gain1.0000
20:63247772:TGTCC:Tacceptor_loss1.0000
20:63247777:T:Gacceptor_loss1.0000
20:63248810:CTCA:Cdonor_loss1.0000
20:63248811:TCACC:Tdonor_loss1.0000
20:63248812:CACCT:Cdonor_loss1.0000
20:63248813:A:ACdonor_gain1.0000
20:63248813:AC:Adonor_gain1.0000
20:63248814:C:CCdonor_gain1.0000
20:63248814:C:CGdonor_loss1.0000
20:63248814:CC:Cdonor_gain1.0000
20:63248891:GTGTA:Gacceptor_gain1.0000
20:63248892:TGTA:Tacceptor_gain1.0000
20:63248893:GTA:Gacceptor_gain1.0000
20:63248893:GTAC:Gacceptor_loss1.0000
20:63248894:TA:Tacceptor_gain1.0000
20:63248894:TAC:Tacceptor_loss1.0000
20:63248895:AC:Aacceptor_loss1.0000
20:63248896:C:CAacceptor_loss1.0000
20:63248896:C:CCacceptor_gain1.0000
20:63248897:T:Gacceptor_loss1.0000
20:63249933:ACCAC:Adonor_gain1.0000

AlphaMissense

1342 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:63248860:G:CN76K0.899
20:63248860:G:TN76K0.899
20:63247599:A:CS150R0.884
20:63247599:A:TS150R0.884
20:63247601:T:GS150R0.884
20:63248865:A:GW75R0.867
20:63248865:A:TW75R0.867
20:63248886:A:GW68R0.852
20:63248886:A:TW68R0.852
20:63250040:G:CF29L0.836
20:63250040:G:TF29L0.836
20:63250042:A:GF29L0.836
20:63242616:G:CF180L0.830
20:63242616:G:TF180L0.830
20:63242618:A:GF180L0.830
20:63247755:G:CF98L0.826
20:63247755:G:TF98L0.826
20:63247757:A:GF98L0.826
20:63249971:G:CF52L0.824
20:63249971:G:TF52L0.824
20:63249973:A:GF52L0.824
20:63250025:C:AW34C0.815
20:63250025:C:GW34C0.815
20:63250055:C:AR24S0.815
20:63250055:C:GR24S0.815
20:63250007:G:CN40K0.795
20:63250007:G:TN40K0.795
20:63242622:A:CF178L0.790
20:63242622:A:TF178L0.790
20:63244024:A:GF178L0.790

dbSNP variants (sampled 300 via entrez): RS1000103456 (20:63245842 A>G), RS1000134541 (20:63245661 C>A,T), RS1000155526 (20:63253750 C>A), RS1000180622 (20:63256541 T>G), RS1000267582 (20:63255373 G>A), RS1000313409 (20:63249201 C>T), RS1000428627 (20:63251062 G>A), RS1000492247 (20:63252703 A>C), RS1000615464 (20:63248582 T>C), RS1000686783 (20:63249399 G>A), RS1000692981 (20:63251696 T>C), RS1000764867 (20:63252371 G>A), RS1001135973 (20:63243650 GT>G), RS1001257150 (20:63245390 C>A), RS1001473942 (20:63249092 C>G,T)

Disease associations

OMIM: gene MIM:612873 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, affects cotreatment, decreases expression6
trichostatin Aaffects cotreatment, decreases expression3
Vorinostataffects cotreatment, decreases expression2
methylmercuric chloridedecreases expression1
sodium arseniteincreases expression1
butyraldehydeincreases expression1
benzo(e)pyreneincreases methylation1
aflatoxin B2increases methylation1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
nutlin 3increases expression1
dorsomorphinaffects cotreatment, decreases expression1
(+)-JQ1 compounddecreases expression1
Benzo(a)pyreneincreases methylation, affects methylation1
Methapyrileneincreases methylation1
Methotrexatedecreases expression1
Oxygendecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases methylation1
Cadmium Chloridedecreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.